Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

P. Zufferey; S. Laporte; S. Molliex; C. Auboyer; P. Mismetti

doi:10.1111/j.1538-7836.2005.01318.x

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

P. Zufferey ¹ S. Laporte ¹ S. Molliex C. Auboyer P. Mismetti ¹

1 GRT (EA 3065) - Groupe de recherche sur la thrombose

Type de document :

Article dans une revue

Journal of Thrombosis and Haemostasis, Wiley, 2005, 3 (5), pp.1104-7. 〈10.1111/j.1538-7836.2005.01318.x〉

Domaine :

Sciences du Vivant [q-bio] / Sciences pharmaceutiques / Pharmacologie

Liste complète des métadonnées

https://hal-ujm.archives-ouvertes.fr/ujm-00439804
Contributeur : Patrick Mismetti <>
Soumis le : mardi 8 décembre 2009 - 15:38:17
Dernière modification le : dimanche 15 octobre 2017 - 22:44:04

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

Lien texte intégral

Identifiants

Collections

Citation

Exporter

Métriques

42

Contact

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

Lien texte intégral

Identifiants

Collections

Citation

Exporter

Partager

Métriques

42

Contact